ArticleTargeted oncology2016

Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer.

Filippo Pietrantonio et al.PubMed ↗Publisher ↗

No numbers read from the abstract.